Monument Capital Management Abb Vie Inc. Transaction History

Monument Capital Management

$358 Million
Q3 2024

A detailed history of Monument Capital Management transactions in Abb Vie Inc. stock. As of the latest transaction made, Monument Capital Management holds 6,556 shares of ABBV stock, worth $1.18 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares

6,556

Previous 6,557 0.02%

Holding current value

$1.18 Million

Previous $1.12 Million 15.12%

% of portfolio

0.36%

Previous 0.34%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	SELL	$163.84 - $199.33 $163 - $199	-1 Reduced 0.02%	6,556 $1.29 Million
Q2 2024 Jul 19, 2024	BUY	$154.79 - $180.76 $13,157 - $15,364	85 Added 1.31%	6,557 $1.12 Million
Q1 2024 Apr 18, 2024	SELL	$159.82 - $182.1 $12,785 - $14,568	-80 Reduced 1.22%	6,472 $1.18 Million
Q4 2023 Feb 01, 2024	SELL	$137.6 - $154.97 $117,923 - $132,809	-857 Reduced 11.57%	6,552 $1.02 Million
Q3 2023 Oct 25, 2023	SELL	$133.59 - $154.65 $668,751 - $774,177	-5,006 Reduced 40.32%	7,409 $1.1 Million
Q2 2023 Jul 18, 2023	SELL	$132.51 - $164.9 $691,702 - $860,778	-5,220 Reduced 29.6%	12,415 $1.67 Million
Q1 2023 Apr 21, 2023	BUY	$144.61 - $166.54 $125,810 - $144,889	870 Added 5.19%	17,635 $2.81 Million
Q4 2022 Jan 26, 2023	BUY	$138.31 - $165.87 $502,618 - $602,771	3,634 Added 27.67%	16,765 $0
Q3 2022 Nov 07, 2022	BUY	$134.21 - $153.93 $36,370 - $41,715	271 Added 2.11%	13,131 $1.76 Million
Q2 2022 Jul 20, 2022	BUY	$137.62 - $174.96 $266,019 - $338,197	1,933 Added 17.69%	12,860 $1.97 Million
Q1 2022 Apr 14, 2022	BUY	$131.98 - $163.75 $9,634 - $11,953	73 Added 0.67%	10,927 $1.77 Million
Q4 2021 Jan 18, 2022	BUY	$107.43 - $135.93 $68,003 - $86,043	633 Added 6.19%	10,854 $1.47 Million
Q3 2021 Oct 22, 2021	BUY	$106.4 - $120.78 $42,240 - $47,949	397 Added 4.04%	10,221 $1.1 Million
Q2 2021 Jul 27, 2021	BUY	$105.21 - $117.21 $271,757 - $302,753	2,583 Added 35.67%	9,824 $1.11 Million
Q1 2021 Apr 12, 2021	SELL	$102.3 - $112.62 $15,958 - $17,568	-156 Reduced 2.11%	7,241 $784,000
Q4 2020 Jan 15, 2021	BUY	$80.49 - $108.67 $595,384 - $803,831	7,397 New	7,397 $793,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Monument Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Monument Capital Management with notifications on news.

Account

Monument Capital Management Abb Vie Inc. Transaction History